Neurotensin: A role in substance use disorder?
- PMID: 26755548
- DOI: 10.1177/0269881115622240
Neurotensin: A role in substance use disorder?
Abstract
Neurotensin is a tridecapeptide originally identified in extracts of bovine hypothalamus. This peptide has a close anatomical and functional relationship with the mesocorticolimbic and nigrostriatal dopamine system. Neural circuits containing neurotensin were originally proposed to play a role in the mechanism of action of antipsychotic agents. Additionally, neurotensin-containing pathways were demonstrated to mediate some of the rewarding and/or sensitizing properties of drugs of abuse.This review attempts to contribute to the understanding of the role of neurotensin and its receptors in drug abuse. In particular, we will summarize the potential relevance of neurotensin, its related compounds and neurotensin receptors in substance use disorders, with a focus on the preclinical research.
Keywords: Agonist; antagonist; behavioral sensitization; conditioned place preference; drug abuse; drug self-administration; hyperlocomotion; neurotensin; neurotensin receptor; preclinical research; review.
© The Author(s) 2016.
Similar articles
-
Neurotensin: role in psychiatric and neurological diseases.Peptides. 2006 Oct;27(10):2385-404. doi: 10.1016/j.peptides.2006.04.024. Epub 2006 Aug 4. Peptides. 2006. PMID: 16891042 Review.
-
Systemic PD149163, a neurotensin receptor 1 agonist, decreases methamphetamine self-administration in DBA/2J mice without causing excessive sedation.PLoS One. 2017 Jul 7;12(7):e0180710. doi: 10.1371/journal.pone.0180710. eCollection 2017. PLoS One. 2017. PMID: 28686721 Free PMC article.
-
Neurotensin, schizophrenia, and antipsychotic drug action.Int Rev Neurobiol. 2004;59:327-49. doi: 10.1016/S0074-7742(04)59013-X. Int Rev Neurobiol. 2004. PMID: 15006494 Review.
-
Novel treatments of schizophrenia: targeting the neurotensin system.CNS Neurol Disord Drug Targets. 2006 Apr;5(2):205-18. doi: 10.2174/187152706776359655. CNS Neurol Disord Drug Targets. 2006. PMID: 16611093 Review.
-
Neurotensin NTS1-dopamine D2 receptor-receptor interactions in putative receptor heteromers: relevance for Parkinson's disease and schizophrenia.Curr Protein Pept Sci. 2014;15(7):681-90. doi: 10.2174/1389203715666140901105253. Curr Protein Pept Sci. 2014. PMID: 25175457 Review.
Cited by
-
Unravelling the Link Between Prenatal Stress, Dopamine and Substance Use Disorder.Neurotox Res. 2017 Jan;31(1):169-186. doi: 10.1007/s12640-016-9674-9. Epub 2016 Oct 24. Neurotox Res. 2017. PMID: 27778246 Review.
-
Effect of D1- and D2-like Dopamine Receptor Antagonists on the Rewarding and Anxiolytic Effects of Neurotensin in the Ventral Pallidum.Biomedicines. 2022 Aug 28;10(9):2104. doi: 10.3390/biomedicines10092104. Biomedicines. 2022. PMID: 36140205 Free PMC article.
-
Neurotensin speeds inhibition of dopamine neurons through temporal modulation of GABAA and GABAB receptor-mediated synaptic input.Neuropharmacology. 2018 Mar 15;131:414-423. doi: 10.1016/j.neuropharm.2018.01.004. Epub 2018 Jan 5. Neuropharmacology. 2018. PMID: 29307543 Free PMC article.
-
Stabilization of pre-existing neurotensin receptor conformational states by β-arrestin-1 and the biased allosteric modulator ML314.Nat Commun. 2023 Jun 7;14(1):3328. doi: 10.1038/s41467-023-38894-8. Nat Commun. 2023. PMID: 37286565 Free PMC article.
-
Role of central neurotensin in regulating feeding: Implications for the development and treatment of body weight disorders.Biochim Biophys Acta Mol Basis Dis. 2018 Mar;1864(3):900-916. doi: 10.1016/j.bbadis.2017.12.036. Epub 2017 Dec 27. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 29288794 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical